editorial | Q871232 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1029392437 |
P356 | DOI | 10.1007/S00066-010-8001-2 |
P698 | PubMed publication ID | 21127826 |
P50 | author | Rita Engenhart-Cabillic | Q29950654 |
Felix Sedlmayer | Q45909425 | ||
P2093 | author name string | Wilfried Budach | |
Frederik Wenz | |||
Marie-Luise Sautter-Bihl | |||
Jürgen Dunst | |||
Rainer Fietkau | |||
Wulf Haase | |||
Rolf Sauer | |||
Claus Rödel | |||
Wolfgang Harms | |||
Rainer Souchon | |||
Petra Feyer | |||
P2860 | cites work | Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial | Q28285969 |
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials | Q29031162 | ||
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). | Q33471876 | ||
Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies | Q36890168 | ||
RBE of low energy electrons and photons | Q37739092 | ||
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. | Q43922051 | ||
Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries | Q43981004 | ||
Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer | Q45041163 | ||
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer | Q45041166 | ||
Pattern of local recurrence after conservative surgery and whole-breast irradiation | Q46427481 | ||
Effect of breathing motion in radiotherapy of breast cancer: 4D dose calculation and motion tracking via EPID. | Q48839598 | ||
Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. | Q50186985 | ||
Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach. | Q51787732 | ||
DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy. | Q53225060 | ||
Surface dose in the treatment of breast cancer with helical tomotherapy. | Q53334310 | ||
IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: results of an ISIORT pooled analysis. | Q53441290 | ||
Preclinical studies with the photon radiosurgery system (PRS). | Q55475597 | ||
Intraoperative radiotherapy for early breast cancer | Q57304481 | ||
Intraoperative radiotherapy for early breast cancer | Q57397740 | ||
The Linear-Quadratic Model Is Inappropriate to Model High Dose per Fraction Effects in Radiosurgery | Q57730424 | ||
Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery | Q70092232 | ||
Clinical relative biological effectiveness of low-energy x-rays emitted by miniature x-ray devices | Q74592446 | ||
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial | Q80495823 | ||
Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications | Q80821826 | ||
Early ipsilateral breast tumor recurrences after breast conservation affect survival: an analysis of the National Cancer Institute randomized trial | Q81814945 | ||
Postoperative irradiation of left-sided breast cancer patients and cardiac toxicity. Does deep inspiration breath-hold (DIBH) technique protect the heart? | Q82639836 | ||
Sphere of equivalence--a novel target volume concept for intraoperative radiotherapy using low-energy X rays | Q82700981 | ||
A dosimetric comparison of IORT techniques in limited-stage breast cancer | Q83351847 | ||
[Is cardiotoxicity still an issue after breast-conserving surgery and could it be reduced by multifield IMRT?] | Q83660712 | ||
Accelerated partial breast irradiation: caution and concern from an ASTRO task force | Q84104789 | ||
Partial breast irradiation: new standard for selected patients | Q84459924 | ||
Accelerated partial-breast irradiation (APBI)--ready for prime time? | Q84637866 | ||
Intraoperative radiotherapy for early breast cancer | Q85122646 | ||
Intraoperative radiotherapy for early breast cancer | Q95028900 | ||
P433 | issue | 12 | |
P304 | page(s) | 651-657 | |
P577 | publication date | 2010-12-01 | |
P1433 | published in | Strahlentherapie und Onkologie | Q15724604 |
P1476 | title | Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer : beware of one-stop shops? | |
P478 | volume | 186 |
Q34203340 | Boost IORT in Breast Cancer: Body of Evidence |
Q33751802 | Breast cancer: Actual methods of treatment and future trends |
Q43572060 | Clinical and technical characteristics of intraoperative radiotherapy. Analysis of the ISIORT-Europe database. |
Q39565830 | Comparison of two radiation techniques for the breast boost in patients undergoing neoadjuvant treatment for breast cancer |
Q37301839 | DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer |
Q51326094 | Dose distribution changes with shielding disc misalignments and wrong orientations in breast IOERT: a Monte Carlo - GEANT4 and experimental study. |
Q45845614 | Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial |
Q48530946 | Frequency of whole breast irradiation (WBRT) after intraoperative radiotherapy (IORT) is strongly influenced by institutional protocol qualification criteria |
Q42316299 | Intraoperative Period and Breast Cancer: Review |
Q34303459 | Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 2--TARGIT |
Q37593615 | Intraoperative radiotherapy (IORT) as boost in breast cancer. |
Q27014710 | Intraoperative radiotherapy for breast cancer: the lasting effects of a fleeting treatment |
Q35976074 | Margins! Margins. Margins? How Important Is Margin Status in Breast-Preserving Therapy? |
Q43644987 | One life saved by four prevented recurrences? Update of the Early Breast Cancer Trialists confirms: postoperative radiotherapy improves survival after breast conserving surgery |
Q56776020 | Procedure for creating a three-dimensional (3D) model for superficial hyperthermia treatment planning |
Q37496835 | Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A. |
Q39476538 | Single dose IOERT versus whole breast irradiation : Cosmetic results in breast-conserving therapy |
Q37947111 | Ultrashort courses of adjuvant breast radiotherapy: wave of the future or a fool's errand? |
Q38056081 | When are breast cancer patients old enough for the quitclaim of local control? |
Q84129791 | [Rules and regulations applying to incidents in radiotherapy] |
Q84806145 | [Technical and methodical developments of radiation oncology from a physician's point of view] |
Search more.